Practice Alert
Practice Alert
Taking steps to slow the upswing in oral and pharyngeal cancers
The CDC estimates that 70% of these cancers are caused by HPV. And yet, in 2018, only about two-thirds of adolescents had received 1 or more doses...
Practice Alert
USPSTF round-up
The Task Force now recommends that physicians take steps to prevent perinatal depression and has modified its recommendation on lead screening.
Practice Alert
ACIP vaccination update
Revisions for HepA concern homelessness, HIV, and vaccine catch-up. MenB booster is advised for those still at increased risk 1 year after...
Practice Alert
Pneumococcal conjugate vaccine update
ACIP no longer recommends routine use of PCV13 in immunocompetent adults ≥ 65 years. Three simple statements summarize guidance on intervals to...
Practice Alert
Influenza update
Consider starting vaccination in September or later to avoid waning immunity by the end of the flu season.
Practice Alert
Facts to help you keep pace with the vaccine conversation
In the United States, we have a robust system to monitor vaccine safety and an efficient system to compensate those who experience adverse...
Practice Alert
2019 USPSTF update
The latest recommendations include 2 topics previously unaddressed: perinatal depression prevention and EKG screening for atrial fibrillation.
Practice Alert
Hepatitis vaccination update
Immunization rates for hepatitis B are still suboptimal; a new 2-dose vaccine may help turn that around. HepA vaccine is now preferred as post-...
Practice Alert
“The Physical Activity Guidelines for Americans”— a summary with tips
Only about 20% of Americans are sufficiently active, according to “The Physical Activity Guidelines for Americans” issued by a Department of...
Practice Alert
A look at new guidelines for HIV treatment and prevention
Start antiretroviral therapy as soon as possible after HIV infection is confirmed. Consider daily PrEP for patients at risk from sexual exposure...
Practice Alert
CDC recommendations for the 2018-2019 influenza season
Vaccines will contain a new A (H3N2) component and B antigen. The live attenuated influenza vaccine returns as an option for those 2- to 49-years...